packageSecukinumab

secukinumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Secukinumab is a monoclonal antibody that blocks interleukin-17 and is used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is an approved medicine authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q7444755 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:secukinumab
ATC codes:L04AC10
DrugBank:DB09029
Wikidata:Q7444755
molar mass:151000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown